News

Lyric Pharmaceuticals Announces $20.4M Series A Funding Round
Lyric Pharmaceuticals Announces $20.4M Series A Funding Round
By

SOUTH SAN FRANCISCO, CA, February 26, 2015 – Lyric Pharmaceuticals Inc. today announced the initial closing of a Series A financing round totaling $20.4 million. The financing, co-led by RiverVest Venture Partners, Santé Ventures and Third Point Ventures, includes participation by Aperture Venture Partners. Lyric is a clinical-stage pharmaceutical company co-founded in 2013 by David Wurtman, M.D., M.B.A., President &